CClinicalTrials.gg
CompletedNCT06897995Updated Mar 27, 2025

Aerobic Exercise on Platelet Mitochondrial Function

An interventional study of EXERCISE TRAINING WITH OR WITHOUT MEDICATION in Sedentary Lifestyle and Aerobic Exercise, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Open to male participants aged 18 Years to 28 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-27.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jul 2023, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 28 Years
Sex
Male
01

Study summary

This study explores how exercise affects blood platelets and their role in clotting. Regular exercise can influence how efficiently clots form in the body. Intense exercise tends to increase platelet activity and the expression of certain molecules on their surface, while moderate exercise can decrease this activity. Since platelets are responsible for blood clotting, understanding how they function can be crucial.

Understanding Platelets:

Platelets are blood cells that help in clotting. The mitochondria within platelets help regulate their function. If these mitochondria don't work properly, it can lead to issues with clotting. By examining how exercise changes platelet mitochondria, the investigators can potentially identify important markers for health and disease progression.

Study Design:

This study compares two types of exercise routines: circuit training and stationary bicycle training.

Participants will be randomly assigned to one of the two groups:

Circuit Training Group: This involves moving through different exercise stations within a set time, targeting various body parts. It's tailored for those who might find regular exercise challenging, helping to reduce fatigue in any single area and improve overall fitness.

Bicycle Training Group: This involves exercising on a stationary bike. Both exercise groups will engage in high-intensity interval training for about 40 minutes, five times a week, over six weeks.

Assessment: Participants will undergo tests to measure endurance and physical function.

Blood Sampling: Blood will be drawn before and after the exercise tests, with 20 milliliters taken from the arm vein. Blood samples will also be collected at the start and end of a 6-week intervention, totaling 80 milliliters throughout the study. This helps the investigators analyze how platelets are affected by exercise.

This study is designed to help the investigators better understand how different types of exercise can benefit platelet function and overall health. Participanting in this research could contribute to the knowledge about how could exercise influence blood clotting and related health conditions. Participants' involvement will include exercise routines or maintaining your current lifestyle, along with simple blood tests. Participation is highly valuable and can help pave the way for new health insights and treatments.

02

Conditions studied

  • Sedentary Lifestyle
  • Aerobic Exercise

Keywords

  • mitochondrial respiration
  • oxidative stress
  • physical exercise
  • thrombocytes
03

In context

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 28 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Willing to sign a written informed consent form.
  • Ages 18 to 28.
  • No regular exercise habit (defined as exercising 2 times a week or less, for 60 minutes or less each time, for over a year).

Exclusion criteria

Exclusion Criteria:

  • Overweight (BMI > 24) or underweight (BMI \< 19).
  • Smoked within the past year, or consumed alcohol in the past month exceeding 60 grams of alcohol per occasion.
  • Having metabolic, circulatory, respiratory, or immune-related diseases or risk factors such as diabetes, hyperlipidemia, hypertension, heart disease, clotting disorders, asthma, allergies, autoimmune diseases, etc.
  • Long-term use of any nutritional supplements or medications (e.g., vitamins, pain relievers, aspirin, traditional Chinese medicine).
  • Significant knee injuries within the past year (e.g., ligament damage, fractures).
  • Students and laboratory staff taught, assessed, evaluated, tested, or appraised by the principal investigator of this study.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Circuit training group

    Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION

  • Active comparator
    Cycle ergometer group

    Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION

Interventions

  • OtherEXERCISE TRAINING WITH OR WITHOUT MEDICATION

    Participants in the exercise groups were trained five times a week for six weeks. The regimen began with a 5-min warm-up and ended with a 5-min cool-down, both at 40% of heart rate reserved (HRR). The circuit training participants were trained for three bouts of 10-min moderate-intensity exercise (60% of HRR) with 1-min rest intervals at a stationary ergometer, a rowing machine, and an elliptical trainer, respectively. The cycling training group was trained on an ergometer for three bouts of 10-min cycling on a stationary ergometer.

06

What researchers measure

Primary outcomes

  1. Platelet mitochondrial respiration

    The mitochondrial OXPHOS and ET capacities in platelets were analyzed.

    Time frame: baseline and 2 days upon the completion of the 6-week intervention

  2. Cardiopulmonary fitness

    Graded Exercise Test was performed on an ergometer.

    Time frame: baseline and 2 days upon the completion of the 6-week intervention

07

Study locations

1 site
  • Chang Gung University
    Taoyuan, 333, Taiwan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06897995
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Jong-Shyan Wang (Prof, Chang Gung Memorial Hospital) — Principal investigator
First posted
Mar 27, 2025
Start date
Jul 1, 2023
Primary completion
May 31, 2024
Completion
May 31, 2024
Last update
Mar 27, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion